Jul 27, 2022 / 11:00AM GMT
Nick Stone -
Hello, everyone. It's Nick as mentioned. Welcome to our first half and Q2 2020 conference call and webcast for investors and analysts. This is our first quarter as a new biopharma company. And earlier today, the presentation was posted to gsk.com. It was also sent by e-mail to our distribution list.
Please turn to Slide 2. This is the usual safe harbor statement, and we'll be making comments on our performance using constant exchange rates, or CR, unless otherwise stated. As a reminder, GSK satisfied the formal criteria according to IFRS 5 for treating Consumer Healthcare as a discontinued operation effective from 30th of June 2022.
The Consumer Healthcare business was demerged on 18th of July to form Haleon. And as a result, we're presenting continuing operations for GSK. Earlier today, Haleon also published a trading update and will be announcing its Q2 results in September.
Please turn to Slide 3. This is today's agenda, where we plan to cover all aspects of our half year and Q2 2020 results. The presentation will last at least 35 minutes with a further 40 minutes for
Q2 2022 GSK plc Earnings Call Transcript
Feb 10, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers